What is the Ривароксабан?

Ривароксабан is , while it's Molecular Formula is C19H18ClN3O5S. Rivaroxaban is a novel antithrombotic agent. It is a novel, oral, selective direct inhibitor of factor Xa developed by Bayer Healthcare. It has been approved by the EMEA and FDA for the prevention ofvenous thromboembolism in adult patients after total hip replacement or total kneereplacement surgery.

What is the CAS number for Ривароксабан?

The CAS number of Ривароксабан is 366789-02-8.

What is Ривароксабан (366789-02-8) used for?

Rivaroxaban is an orally active, direct inhibitor of Factor Xa (Ki = 0.4 nM), which is a crucial component of the intrinsic and extrinsic pathways of the blood coagulation cascade. It demonstrates >10,000-fold greater selectivity for Factor Xa compared to other related serine proteases (thrombin, trypsin, plasmin, FVIIa, FIXa, FXIa, urokinase, and activated protein C). In various animal arterial and venous thrombosis models, rivaroxaban is reported to inhibit thrombin formation without prolonging bleeding time and has been approved for clinical use as an anticoagulant in the prevention of stroke and the treatment of venous thromboembolisms.InChI:InChI=1/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1

What is the Ривароксабан?

Ривароксабан is , while it's Molecular Formula is C19H18ClN3O5S. Rivaroxaban is a novel antithrombotic agent. It is a novel, oral, selective direct inhibitor of factor Xa developed by Bayer Healthcare. It has been approved by the EMEA and FDA for the prevention ofvenous thromboembolism in adult patients after total hip replacement or total kneereplacement surgery.

What is the CAS number for Ривароксабан?

The CAS number of Ривароксабан is 366789-02-8.

What is Ривароксабан (366789-02-8) used for?

Rivaroxaban is an orally active, direct inhibitor of Factor Xa (Ki = 0.4 nM), which is a crucial component of the intrinsic and extrinsic pathways of the blood coagulation cascade. It demonstrates >10,000-fold greater selectivity for Factor Xa compared to other related serine proteases (thrombin, trypsin, plasmin, FVIIa, FIXa, FXIa, urokinase, and activated protein C). In various animal arterial and venous thrombosis models, rivaroxaban is reported to inhibit thrombin formation without prolonging bleeding time and has been approved for clinical use as an anticoagulant in the prevention of stroke and the treatment of venous thromboembolisms.InChI:InChI=1/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1

Каталог товаров

366789-02-8

английское имя：Ривароксабан
Брутто-формула：C₁₉H₁₈ClN₃O₅S
Степень чистоты：99%
Молярная масса：435.888

Узнать цену

информация о продукте;

CAS номер： 366789-02-8

Брутто-формула： C₁₉H₁₈ClN₃O₅S

Ривароксабан также известно как . Ривароксабан представлено символом C19H18ClN3O5S, который состоит из 19 атомов Углерод,18 атомов Водород,1 атома Хлор,3 атомов Азот,5 атомов Кислород и 1 атома Сера..

сопутствующие товары

(±) Clopidogrel hydrogensulfate
CAS：135046-48-9
7H-Pyrido [1,2,3-de] -1,4-бензоксазин-6-карбоксиликислота, 9,10-дифтор-2,3-дигидро-3-метил-7-оксо-, (3S)-
CAS：100986-89-8
4-амино-3-фторфенол
CAS：399-95-1

Каталог товаров

366789-02-8

информация о продукте;

сопутствующие товары

Site_Map

Рекомендуем

Связаться с нами

Link Us